The over-the-counter (OTC) derivatives market is increasingly the focus of the US legislative agenda. While the flurry of bills and pronouncements have done little to add substance to that framework, they have made one thing abundantly clear: OTC derivatives will be subject to a new regulatory landscape. One common thread among all is transparency; however, the road to achieving that is rife with blind corners.

Please join us for the next 30 minute teleconference in our continuing series where we address areas of overlap, conflict, what's still unresolved, and how the growing amount of derivatives litigation may cloud various regulatory proposals.

Listen to audio recording >>

Mayer Brown's Global Financial Markets Initiative helps clients deal with the legal and business challenges resulting from the ongoing turbulence in worldwide financial markets. By mobilizing the firm's global resources from multiple practices and offices, the Initiative provides clients with knowledgeable and timely counsel on a broad spectrum of their legal needs.

Visit Mayer Brown's Financial Market Distress - Resources site for a compilation of links to the latest documents issued by regulatory and other governmental agencies worldwide, and additional commentary by Mayer Brown. Please bookmark it and check back often to stay informed on this rapidly evolving situation.